1 824 170 EFFECT OF YOGA ON GLYCEMIA AND LIPID PARAMETERS IN TYPE-2 DIABETES: A META-ANALYSIS. PURPOSE: PRIOR SYSTEMATIC REVIEWS ON YOGA AND DIABETES HAVE GIVEN CONFLICTING RESULTS. THEY HAVE BEEN LIMITED BY INCLUSION OF UNCONTROLLED UNBLINDED SINGLE GROUP OBSERVATIONAL STUDIES. NO REVIEWS ARE AVAILABLE WHICH HAVE USED THE COCHRANE METHODOLOGY AND GRADE (GRADES OF RECOMMENDATION, ASSESSMENT, DEVELOPMENT AND EVALUATION) APPROACH. THIS META-ANALYSIS EVALUATED THE EFFICACY OF YOGA ON GLYCAEMIA AND LIPIDS IN T2DM USING THE COCHRANE METHODOLOGY AND GRADE APPROACH. METHODS: MAJOR REPOSITORIES WERE SEARCHED TO PICK RANDOMIZED CONTROLLED TRIALS INVOLVING T2DM PATIENTS RECEIVING YOGA. PRIMARY OUTCOME WAS TO EVALUATE CHANGES IN FASTING PLASMA GLUCOSE (FPG) AND GLYCATED HAEMOGLOBIN (HBA1C). SECONDARY OUTCOMES WERE TO EVALUATE CHANGES IN POST-PRANDIAL PLASMA GLUCOSE (PPG), TOTAL CHOLESTEROL (TC), TRIGLYCERIDES, LOW-DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL (HDL-C). SUB-GROUP ANALYSIS INVOLVING PEOPLE UNDERGOING STRUCTURED EXERCISE REGIMEN (SER) VERSUS THOSE UNDERGOING STANDARD DIABETES CARE IN CONTROLS WAS DONE. RESULTS: DATA FROM 13 STUDIES INVOLVING 1440 PATIENTS WERE ANALYSED. COMPARED TO CONTROLS, INDIVIDUALS DOING YOGA HAD SIGNIFICANTLY LOWER FPG [MEAN DIFFERENCE (MD) -17.22 MG/DL (95% CI: -26.19 - -8.26 MG/DL); P < 0.01; CONSIDERABLE HETEROGENEITY (CH); LOW CERTAINTY OF EVIDENCE (LCE)], PPG [MD -27.77 MG/DL (95% CI: -35.73 - -19.81 MG/DL); P < 0.01; LOW HETEROGENEITY; MODERATE CERTAINTY OF EVIDENCE (MCE)], TC [MD -19.48 MG/DL (95% CI: -31.97 - -6.99 MG/DL); P < 0.01; CH; LCE], TRIGLYCERIDES [MD -12.99 MG/DL (95% CI: -23.74 - -2.25 MG/DL); P < 0.01; CH; LCE], LDL-C [MD -11.71 MG/DL (95% CI: -17.49 - -5.93 MG/DL); P < 0.01; I(2) = 69% CH; LCE] AND SIGNIFICANTLY HIGHER HDL-C [MD 4.58 MG/DL (95% CI: 3.98-5.18 MG/DL); P < 0.01; LOW HETEROGENEITY; MCE]. ON SUB-GROUP ANALYSIS, WHERE YOGA WAS COMPARED TO SER, FPG WAS SIGNIFICANTLY LOWER IN YOGA GROUP. CONCLUSION: YOGA IMPROVES GLYCAEMIA AND LIPID PARAMETERS IN T2DM WITH ADDITIONAL BENEFITS SEEN BOTH IN PEOPLE DOING/NOT DOING STRUCTURED EXERCISE. SUPPLEMENTARY INFORMATION: THE ONLINE VERSION CONTAINS SUPPLEMENTARY MATERIAL AVAILABLE AT 10.1007/S40200-021-00751-0. 2021 2 1033 53 EFFECTS OF YOGA IN ADULTS WITH TYPE 2 DIABETES MELLITUS: A META-ANALYSIS. AIMS/INTRODUCTION: A META-ANALYSIS WAS CARRIED OUT TO EVALUATE THE EFFICACY OF YOGA IN ADULTS WITH TYPE 2 DIABETES MELLITUS. MATERIALS AND METHODS: THE PUBMED, EMBASE AND COCHRANE DATABASES WERE SEARCHED TO OBTAIN ELIGIBLE RANDOMIZED CONTROLLED TRIALS. THE PRIMARY OUTCOME WAS FASTING BLOOD GLUCOSE, AND THE SECONDARY OUTCOMES INCLUDED GLYCOSYLATED HEMOGLOBIN A1C, TOTAL CHOLESTEROL, HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, LOW-DENSITY LIPOPROTEIN CHOLESTEROL, TRIGLYCERIDE AND POSTPRANDIAL BLOOD GLUCOSE. WEIGHTED MEAN DIFFERENCES AND 95% CONFIDENCE INTERVALS (CIS) WERE CALCULATED. THE I(2) STATISTIC REPRESENTED HETEROGENEITY. RESULTS: A TOTAL OF 12 RANDOMIZED CONTROLLED TRIALS WITH A TOTAL OF 864 PATIENTS MET THE INCLUSION CRITERIA. THE POOLED WEIGHTED MEAN DIFFERENCES WERE -23.72 MG/DL (95% CI -37.78 TO -9.65; P = 0.001; I(2) = 82%) FOR FASTING BLOOD GLUCOSE AND -0.47% (95% CI -0.87 TO -0.07; P = 0.02; I(2) = 82%) FOR HEMOGLOBIN A1C. THE WEIGHTED MEAN DIFFERENCES WERE -17.38 MG/DL (95% CI -27.88 TO -6.89; P = 0.001; I(2) = 0%) FOR POSTPRANDIAL BLOOD GLUCOSE, -18.50 MG/DL (95% CI -29.88 TO -7.11; P = 0.001; I(2) = 75%) FOR TOTAL CHOLESTEROL, 4.30 MG/DL (95% CI 3.25 TO 5.36; P < 0.00001; I(2) = 10%) FOR HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, -12.95 MG/DL (95% CI -18.84 TO -7.06; P < 0.0001; I(2) = 37%) FOR LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND -12.57 MG/DL (95% CI -29.91 TO 4.76; P = 0.16; I(2) = 48%) FOR TRIGLYCERIDES. CONCLUSIONS: THE AVAILABLE EVIDENCE SUGGESTS THAT YOGA BENEFITS ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS. HOWEVER, CONSIDERING THE LIMITED METHODOLOGY AND THE POTENTIAL HETEROGENEITY, FURTHER STUDIES ARE NECESSARY TO SUPPORT OUR FINDINGS AND INVESTIGATE THE LONG-TERM EFFECTS OF YOGA IN TYPE 2 DIABETES MELLITUS PATIENTS. 2017 3 2161 41 THE EFFECTS OF YOGA AMONG ADULTS WITH TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS. THE PURPOSE OF THIS META-ANALYSIS WAS TO EXAMINE THE EFFECTS OF YOGA FOR GLYCEMIC CONTROL AMONG ADULTS WITH TYPE 2 DIABETES (T2DM). COMPREHENSIVE ELECTRONIC DATABASES SEARCHES LOCATED 2559 UNIQUE STUDIES WITH RELEVANT KEY TERMS. STUDIES WERE INCLUDED IF THEY (1) EVALUATED A YOGA INTERVENTION TO PROMOTE T2DM MANAGEMENT, (2) USED A COMPARISON GROUP, (3) REPORTED AN OBJECTIVE MEASURE OF GLYCEMIC CONTROL AT POST-INTERVENTION, AND (4) HAD FOLLOW-UP LENGTH OR POST-TEST OF AT LEAST 8WEEKS FROM BASELINE. INDEPENDENT RATERS CODED PARTICIPANT, DESIGN AND METHODOLOGICAL CHARACTERISTICS AND INTERVENTION CONTENT. SUMMARY EFFECT SIZES AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED. TWENTY-THREE STUDIES WITH 2473 PARTICIPANTS (MEAN AGE=53YEARS; 43% WOMEN) MET ELIGIBILITY CRITERIA. COMPARED WITH CONTROLS, YOGA PARTICIPANTS WERE SUCCESSFUL IN IMPROVING THEIR HBA1C (D+=0.36, 95% CI=0.16, 0.56; K=16), FBG (D+=0.58, 95% CI=0.40, 0.76; K=20), AND PPBG (D+=0.40, 95% CI=0.23, 0.56; K=14). YOGA WAS ALSO ASSOCIATED WITH SIGNIFICANT IMPROVEMENTS IN LIPID PROFILE, BLOOD PRESSURE, BODY MASS INDEX, WAIST/HIP RATIO AND CORTISOL LEVELS. OVERALL, STUDIES SATISFIED AN AVERAGE OF 41% OF THE METHODOLOGICAL QUALITY (MQ) CRITERIA; MQ SCORE WAS NOT ASSOCIATED WITH ANY OUTCOME (PS >0.05). YOGA IMPROVED GLYCEMIC OUTCOMES AND OTHER RISK FACTORS FOR COMPLICATIONS IN ADULTS WITH T2DM RELATIVE TO A CONTROL CONDITION. ADDITIONAL STUDIES WITH LONGER FOLLOW-UPS ARE NEEDED TO DETERMINE THE LONG-TERM EFFICACY OF YOGA FOR ADULTS WITH T2DM. 2017 4 828 41 EFFECT OF YOGA ON LIPID PROFILE AND C-REACTIVE PROTEIN IN WOMEN. BACKGROUND: FEW SCIENTIFIC STUDIES HAVE BEEN CONDUCTED ABOUT THE EFFECT OF YOGA ON BIOCHEMICAL VARIABLES SUCH AS TOTAL CHOLESTEROL (TC), HIGH-DENSITY LIPOPROTEIN CHOLESTEROL (HDL-C), LOW-DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C), TRIGLYCERIDE (TG), AND C-REACTIVE PROTEIN (CRP) TO LAY A SCIENTIFIC FOUNDATION REGARDING BENEFITS OF YOGA, BUT ITS EFFECT IS NOT CLEARLY DETECTED YET. THIS STUDY WAS CONDUCTED TO ASSESS THE EFFECT OF YOGA ON LIPID PROFILE AND CRP IN WOMEN. METHODS: THIS RESEARCH WAS DESIGNED AS AN INTERVENTIONAL STUDY. AFTER REVIEWING INCLUSION AND EXCLUSION CRITERIA, SELECTED BIOCHEMICAL VARIABLES SUCH AS TC, HDL-C, LDL-C, TG, AND CRP WERE MEASURED FOR EACH PARTICIPANT. YOGA INSTRUCTION WAS DONE THREE TIMES A WEEK FOR 26 WEEKS BY AN EXPERIENCED YOGA INSTRUCTOR. AFTER 26 WEEKS OF YOGA INTERVENTION, THE ABOVE-MENTIONED DEPENDENT VARIABLES WERE ASSESSED. SPSS VER. 16 WAS USED FOR DATA ANALYSIS. RESULTS: AFTER A 26-WEEK FOLLOW-UP FOR PARTICIPANTS, ONLY 24 WOMEN HAD THE NECESSARY CRITERIA TO BE INCLUDED IN THE STUDY. THE MEAN TG WAS 157.33 +/- 68.416 MG/DL AND 134.33 +/- 58.80 MG/DL BEFORE AND AFTER THE INTERVENTION (P = 0.108), RESPECTIVELY. THE MEAN TC WAS 234.83 +/- 48.47 MG/DL AND 183.33 +/- 55.09 MG/DL BEFORE AND AFTER THE INTERVENTION (P = 0.014), RESPECTIVELY. THE MEAN HDL-C WAS 31.58 +/- 14.22 MG/DL AND 38.25 +/- 13.5 MG/DL BEFORE AND AFTER THE INTERVENTION (P = 0.118), RESPECTIVELY. THE MEAN LDL-C WAS 171.75 +/- 42.69 MG/DL AND 142.91 +/- 36.4 MG/DL BEFORE AND AFTER THE INTERVENTION (P = 0.030), RESPECTIVELY. THE MEAN CRP WAS 0.57 +/- 0.22 MG/L AND 0.71 +/- 0.77 MG/L BEFORE AND AFTER THE INTERVENTION (P = 0.779), RESPECTIVELY. CONCLUSIONS: THE RESULT SHOWED THAT YOGA REDUCED TC AND LDL-C SIGNIFICANTLY, BUT HAD NO SIGNIFICANT EFFECT ON TG, HDL-C, AND CRP. 2019 5 2128 50 THE EFFECTIVENESS OF YOGA IN MODIFYING RISK FACTORS FOR CARDIOVASCULAR DISEASE AND METABOLIC SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. BACKGROUND: YOGA, A POPULAR MIND-BODY PRACTICE, MAY PRODUCE CHANGES IN CARDIOVASCULAR DISEASE (CVD) AND METABOLIC SYNDROME RISK FACTORS. DESIGN: THIS WAS A SYSTEMATIC REVIEW AND RANDOM-EFFECTS META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (RCTS). METHODS: ELECTRONIC SEARCHES OF MEDLINE, EMBASE, CINAHL, PSYCINFO, AND THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS WERE PERFORMED FOR SYSTEMATIC REVIEWS AND RCTS THROUGH DECEMBER 2013. STUDIES WERE INCLUDED IF THEY WERE ENGLISH, PEER-REVIEWED, FOCUSED ON ASANA-BASED YOGA IN ADULTS, AND REPORTED RELEVANT OUTCOMES. TWO REVIEWERS INDEPENDENTLY SELECTED ARTICLES AND ASSESSED QUALITY USING COCHRANE'S RISK OF BIAS TOOL. RESULTS: OUT OF 1404 RECORDS, 37 RCTS WERE INCLUDED IN THE SYSTEMATIC REVIEW AND 32 IN THE META-ANALYSIS. COMPARED TO NON-EXERCISE CONTROLS, YOGA SHOWED SIGNIFICANT IMPROVEMENT FOR BODY MASS INDEX (-0.77 KG/M(2) (95% CONFIDENCE INTERVAL -1.09 TO -0.44)), SYSTOLIC BLOOD PRESSURE (-5.21 MMHG (-8.01 TO -2.42)), LOW-DENSITY LIPOPROTEIN CHOLESTEROL (-12.14 MG/DL (-21.80 TO -2.48)), AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL (3.20 MG/DL (1.86 TO 4.54)). SIGNIFICANT CHANGES WERE SEEN IN BODY WEIGHT (-2.32 KG (-4.33 TO -0.37)), DIASTOLIC BLOOD PRESSURE (-4.98 MMHG (-7.17 TO -2.80)), TOTAL CHOLESTEROL (-18.48 MG/DL (-29.16 TO -7.80)), TRIGLYCERIDES (-25.89 MG/DL (-36.19 TO -15.60), AND HEART RATE (-5.27 BEATS/MIN (-9.55 TO -1.00)), BUT NOT FASTING BLOOD GLUCOSE (-5.91 MG/DL (-16.32 TO 4.50)) NOR GLYCOSYLATED HEMOGLOBIN (-0.06% HB (-0.24 TO 0.11)). NO SIGNIFICANT DIFFERENCE WAS FOUND BETWEEN YOGA AND EXERCISE. ONE STUDY FOUND AN IMPACT ON SMOKING ABSTINENCE. CONCLUSIONS: THERE IS PROMISING EVIDENCE OF YOGA ON IMPROVING CARDIO-METABOLIC HEALTH. FINDINGS ARE LIMITED BY SMALL TRIAL SAMPLE SIZES, HETEROGENEITY, AND MODERATE QUALITY OF RCTS. 2016 6 2118 55 THE EFFECT OF YOGA PRACTICE ON GLYCEMIC CONTROL AND OTHER HEALTH PARAMETERS IN THE PREDIABETIC STATE: A SYSTEMATIC REVIEW AND META-ANALYSIS. A SYSTEMATIC REVIEW AND META-ANALYSIS WAS CONDUCTED TO INVESTIGATE THE EFFECTS OF YOGA ON GLYCEMIC CONTROL, LIPID PROFILES, BODY COMPOSITION AND BLOOD PRESSURE IN PEOPLE IN THE PRE-DIABETIC STATE. STUDIES ON THE EFFECTIVENESS OF YOGA ON POPULATION GROUPS UNDER HIGH RISK FOR DIABETES, CALLED PREDIABETIC OR SUFFERING FROM METABOLIC SYNDROMES WERE EXTRACTED FROM A THOROUGH SEARCH OF PUBMED, SCOPUS, COCHRANE LIBRARY, EBSCO AND INDMED DATABASES. BOTH RANDOMISED CONTROLLED TRIAL (RCT) AND NON-RCT STUDIES WERE INCLUDED IN THE SYSTEMATIC REVIEW AND META-ANALYSIS. STUDIES PUBLISHED BETWEEN JAN 2002 AND DEC 2018 WERE INCLUDED. STUDIES WERE CONSIDERED FOR EVALUATION IF THEY INVESTIGATED A YOGA INTERVENTION TO PREVENT T2DM, AGAINST A CONTROL GROUP, WHILE ALSO REPORTING GLYCEMIC CONTROL AND OTHER HEALTH PARAMETERS OF T2DM MANAGEMENT. SUMMARY EFFECT SIZES AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED USING THE COMPREHENSIVE META-ANALYSIS SOFTWARE IN ADDITION TO PUBLICATION BIAS. OF THE 46,500 IDENTIFIED STUDIES, 14 STUDIES WITH 834 PARTICIPANTS OF WHOM WERE 50% WOMEN, WERE FOUND TO BE ELIGIBLE FOR INCLUSION IN OUR SYSTEMATIC REVIEW. OUR QUANTITATIVE SYNTHESIS INCLUDED 12 RANDOMIZED CONTROL TRIALS AND 2 NON-RANDOMIZED CONTROL TRIALS, WITH THE FOLLOW-UP PERIOD RANGING FROM 4 TO 52 WEEKS. COMPARED TO CONTROLS, YOGA INTERVENTION IMPROVED FASTING BLOOD GLUCOSE (FBG) [STANDARD MEAN DIFFERENCE (SMD -0.064 MG/DL (95% CI -0.201 TO 0.074)]; LOW DENSITY LIPOPROTEIN (LDL) [SMD-0.090 MG/DL (95% CI -0.270 TO 0.090)]; TRIGLYCERIDES [SMD -0.148 MG/DL (95% CI -0.285 TO -0.012)]; TOTAL CHOLESTEROL [SMD -0.058 MG/DL (95% CI -0.220 TO 0.104)] AND SYSTOLIC BLOOD PRESSURE [SMD -0.058 MM HG (95% CI -0.168 TO 0.053)]. THIS META-ANALYSIS UNCOVERED CLINICALLY IMPROVED EFFECTS OF YOGA INTERVENTION ON GLYCEMIC CONTROL, LIPID PROFILES AND OTHER PARAMETERS OF T2DM MANAGEMENT IN PREDIABETIC POPULATION. THESE RESULTS SUGGEST THAT YOGA INTERVENTION MAY BE CONSIDERED AS A COMPREHENSIVE AND ALTERNATIVE APPROACH TO PREVENTING T2DM. FURTHER ADEQUATELY POWERED, WELL DESIGNED RCTS ARE NEEDED TO SUPPORT OUR FINDINGS AND INVESTIGATE THE LONG-TERM EFFECTS OF YOGA IN T2DM PATIENTS. 2019 7 1116 39 EFFICACY OF A VALIDATED YOGA PROTOCOL ON DYSLIPIDEMIA IN DIABETES PATIENTS: NMB-2017 INDIA TRIAL. BACKGROUND: DYSLIPIDEMIA IS CONSIDERED A RISK FACTOR IN TYPE 2 DIABETES MELLITUS (T2DM) RESULTING IN CARDIO-VASCULAR COMPLICATIONS. YOGA PRACTICES HAVE SHOWN PROMISING RESULTS IN ALLEVIATING TYPE 2 DIABETES PATHOLOGY. METHOD: IN THIS STRATIFIED TRIAL ON A YOGA BASED LIFESTYLE PROGRAM IN CASES WITH TYPE 2 DIABETES, IN THE RURAL AND URBAN POPULATION FROM ALL ZONES OF INDIA, A TOTAL OF 17,012 ADULTS (>20 YEARS) OF BOTH GENDERS WERE SCREENED FOR LIPID PROFILE AND SUGAR LEVELS. THOSE WHO SATISFIED THE SELECTION CRITERIA WERE TAUGHT THE DIABETES YOGA PROTOCOL (DYP) FOR THREE MONTHS AND THE DATA WERE ANALYZED. RESULTS: AMONG THOSE WITH DIABETES, 29.1% HAD ELEVATED TOTAL CHOLESTEROL (TC > 200 MG/DL) LEVELS THAT WERE HIGHER IN URBAN (69%) THAN RURAL (31%) DIABETES PATIENTS. THERE WAS A POSITIVE CORRELATION (P = 0.048) BETWEEN HBA1C AND TOTAL CHOLESTEROL LEVELS. DYP INTERVENTION HELPED IN REDUCING TC FROM 232.34 +/- 31.48 MG/DL TO 189.38 +/- 40.23 MG/DL WITH SIGNIFICANT PRE POST DIFFERENCE (P < 0.001). CONVERSION RATE FROM HIGH TC (>200 MG/DL) TO NORMAL TC (<200 MG/DL) WAS OBSERVED IN 60.3% OF CASES WITH TYPE 2 DIABETES MELLITUS (T2DM); FROM HIGH LDL (>130 MG/DL) TO NORMAL LDL (<130 MG/DL) IN 73.7%; FROM HIGH TRIGLYCERIDE (>200 MG/DL) TO NORMAL TRIGLYCERIDE LEVEL (<200 MG/DL) IN 63%; FROM LOW HDL (<45 MG/DL) TO NORMAL HDL (>45 MG/DL) IN 43.7% OF T2DM PATIENTS AFTER THREE MONTHS OF DYP. CONCLUSIONS: A YOGA LIFESTYLE PROGRAM DESIGNED SPECIFICALLY TO MANAGE DIABETES HELPS IN REDUCING THE CO-MORBIDITY OF DYSLIPIDEMIA IN CASES OF PATIENTS WITH T2DM. 2019 8 754 34 EFFECT OF SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION ON PLASMA GLUCOSE LEVELS IN INDIVIDUALS WITH DIABETES AND PRE-DIABETES IN THE COMMUNITY. AIM: TO STUDY THE EFFECT OF SHORT TERM YOGA-BASED LIFESTYLE INTERVENTION IN THE MANAGEMENT OF DIABETES AND PRE-DIABETES, THROUGH A 'PILOT' COMMUNITY-BASED STUDY. METHODS: A TOTAL OF 1292 SUBJECTS WITH DIAGNOSED TYPE 2 DIABETES AND PRE-DIABETES WERE RECRUITED FROM DIFFERENT STATES OF INDIA VIZ., KARNATAKA, MAHARASHTRA, GUJARAT, RAJASTHAN, AND TAMILNADU PARTICIPATED IN THE STUDY. YOGA-BASED LIFESTYLE INTERVENTION WAS INTRODUCED THROUGH 10-DAY NON-RESIDENTIAL CAMPS. BASELINE AND POST INTERVENTION ASSESSMENTS OF FASTING PLASMA GLUCOSE (FPG) WERE MEASURED ON THE FIRST DAY AND TENTH DAY RESPECTIVELY. OF 1292 SUBJECTS, 896 BOTH PRE- AND POST- FPG READINGS WERE AVAILABLE. DATA ANALYSIS WAS DONE USING STATISTICAL PACKAGE FOR THE SOCIAL SCIENCES (SPSS), VERSION 16. RESULTS: MEAN BASELINE FPG LEVEL WAS 133.1 (+/-47.98) AND THE MEAN POST INTERVENTION FPG REDUCED TO 121.19 (+/-40.56). THERE WAS A STATISTICALLY SIGNIFICANT DECREASE IN FPG, P VALUE (<0.0001). CONCLUSION: THE RESULT SUGGESTS THAT A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION EFFECTIVELY REDUCES FPG LEVELS IN TYPE 2 DIABETES PATIENTS AND PRE-DIABETES. 2017 9 2463 36 YOGA AS A THERAPEUTIC INTERVENTION FOR THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS. PURPOSE: THIS STUDY AIMED TO INVESTIGATE THE EFFECTS OF 12 WEEKS YOGIC INTERVENTION ON BLOOD SUGAR AND LIPID PROFILE IN ELDER WOMEN WITH TYPE 2 DIABETES MELLITUS (T2DM). SUBJECTS AND METHODS: TWENTY ELDERLY (AGE RANGE 55-70 YEARS) T2DM WOMEN WERE DIVIDED INTO TWO GROUPS, NAMELY, YOGIC INTERVENTION GROUP (YIG: N = 10, AGE 64.70 +/- 4.03, BODY MASS INDEX [BMI] 24.26 +/- 3.40) AND CONTROL GROUP (CG: N = 10, AGE 64.40 +/- 4.79, BMI 24.28 +/- 2.36). YIG UNDERWENT YOGA PRACTICE (ASANAS, KRIYAS, PRANAYAMAS) FOR 12 WEEKS (3 SESSIONS/WEEK), WHILE THE CG CONTINUED THEIR USUAL ROUTINE ACTIVITIES. STANDING HEIGHT, BODY WEIGHT, BMI, BLOOD SUGAR, AND LIPID PROFILE WERE MEASURED BEFORE COMMENCEMENT AND AFTER 6 AND 12 WEEKS OF YOGIC INTERVENTION IN BOTH GROUPS. RESULTS: THERE WAS A SIGNIFICANT (P < 0.01) DECREASE IN FASTING PLASMA GLUCOSE, POSTPRANDIAL BLOOD SUGAR, TOTAL CHOLESTEROL, TRIGLYCERIDES, LOW-DENSITY LIPOPROTEIN, AND VERY LOW DENSITY LIPOPROTEIN, WITH A SIGNIFICANT (P < 0.01) INCREASE IN HIGH-DENSITY LIPOPROTEIN LEVEL FROM ITS INITIAL VALUE IN YIG, WHILE SHOWING INSIGNIFICANT RESULT IN CG. CONCLUSION: IT CAN BE SAID THAT YOGIC INTERVENTION MAY HAVE THE BENEFICIAL EFFECTS ON BLOOD SUGAR AND LIPID PROFILE IN ELDERLY WOMEN WITH T2DM. 2018 10 2154 46 THE EFFECTS OF THAI YOGA ON PHYSICAL FITNESS: A META-ANALYSIS OF RANDOMIZED CONTROL TRIALS. OBJECTIVES: THAI YOGA IS A TRADITIONAL THAI EXERCISE USED FOR IMPROVING HEALTH-RELATED PHYSICAL FITNESS. MANY STUDIES HAVE EVALUATED THESE EFFECTS, BUT THEIR RESULTS REMAIN INCONCLUSIVE. THIS META-ANALYSIS AIMED TO EXAMINE THE EFFECTIVENESS OF THAI YOGA ON PHYSICAL FITNESS. DESIGN/METHODS: PUBMED, EMBASE, CINAHL, COCHRANE LIBRARY, THAI LIBRARY INTEGRATED SYSTEM (THAILIS), PHYSIOTHERAPY EVIDENCE DATABASE (PEDRO), NATIONAL REHABILITATION INFORMATION CENTER (REHABDATA), SCOPUS, WEB OF SCIENCE, THAI UNIVERSITY LIBRARY DATABASES/JOURNALS, AND THAI PHYSICAL THERAPY DATABASE UP TO MARCH 2016 WERE SEARCHED FOR RANDOMIZED CONTROLLED TRIALS (RCTS) EXAMINING THE EFFECT OF THAI YOGA EXERCISE COMPARED WITH NORMAL DAILY ACTIVITIES AS CONTROLS, IN ANY LANGUAGE. THE WEIGHTED MEAN DIFFERENCE (WMD) AND 95% CONFIDENCE INTERVALS (95% CI) WERE PERFORMED USING THE RANDOM-EFFECTS MODEL. RESULTS: SEVEN RCTS MET THE INCLUSION CRITERIA. THAI YOGA TRAINING SIGNIFICANTLY IMPROVED BODY FLEXIBILITY BY 3.9 CM AFTER 4 WEEKS [95% CI = 3.9-4.0; P < 0.001: NO HETEROGENEITY CHI(2) = 0.66, D.F.2, P = 0.7; I(2) 0.00%] AND 8.9 CM AFTER 8 WEEKS [95% CI = 7.4-10.5; P < 0.001: NO HETEROGENEITY CHI(2) = 0.16, D.F.2, P = 0.9; I(2) 0.00%] COMPARED TO CONTROLS. IT ALSO SIGNIFICANTLY INCREASED RANGE OF MOTION (ROM) OF RIGHT SHOULDER EXTENSION BY 1.5 DEGREES AT WEEK 8, COMPARED TO CONTROLS [95% CI = 0.12-2.81; P = 0.03; LOW HETEROGENEITY CHI(2) = 1.61, D.F.1, P = 0.2; I(2) 37.9%]. GREATER ROM FOR RIGHT SHOULDER ABDUCTION WAS OBSERVED AFTER 12 WEEKS COMPARED TO CONTROLS [22.2 DEGREES (95% CI = 20-24; P < 0.001): NO HETEROGENEITY CHI(2) = 0.29, D.F.1, P = 0.6; I(2) 0.00%]. CONCLUSIONS: THAI YOGA EXERCISES APPEARED USEFUL, IN PARTICULAR, ON BODY AND RIGHT SHOULDER JOINT FLEXIBILITY. REGULAR STRETCHING EXERCISE OF THAI YOGA AND/OR IN COMBINATION WITH EXERCISES COULD PROMOTE HEALTH-RELATED PHYSICAL FITNESS. 2018 11 221 45 A SYSTEMATIC REVIEW AND META-ANALYSIS OF YOGA FOR HYPERTENSION. BACKGROUND: THE AIM OF THIS SYSTEMATIC REVIEW AND META-ANALYSIS WAS TO EVALUATE THE QUALITY OF EVIDENCE AND THE STRENGTH OF RECOMMENDATION FOR YOGA AS A THERAPEUTIC MEANS IN THE MANAGEMENT OF PREHYPERTENSION AND HYPERTENSION. METHODS: MEDLINE/PUBMED, SCOPUS, CENTRAL, AND INDMED WERE SCREENED THROUGH FEBRUARY 2014 FOR RANDOMIZED CONTROLLED TRIALS (RCTS) ON THE EFFECTS OF YOGA INTERVENTIONS (>/=8 WEEKS) COMPARED WITH USUAL CARE OR ANY ACTIVE CONTROL INTERVENTION ON BLOOD PRESSURE IN PATIENTS WITH PREHYPERTENSION (120-139/80-89 MM HG) OR HYPERTENSION (>/=140/>/=90 MM HG). RISK OF BIAS WAS ASSESSED USING THE COCHRANE RISK OF BIAS TOOL; QUALITY OF EVIDENCE WAS ASSESSED ACCORDING TO THE GRADE RECOMMENDATIONS. RESULTS: SEVEN RCTS WITH A TOTAL OF 452 PATIENTS WERE INCLUDED. COMPARED WITH USUAL CARE, VERY LOW-QUALITY EVIDENCE WAS FOUND FOR EFFECTS OF YOGA ON SYSTOLIC (6 RCTS, N = 278; MEAN DIFFERENCE (MD) = -9.65 MM HG, 95% CONFIDENCE INTERVAL (CI) = -17.23 TO -2.06, P = 0.01; HETEROGENEITY: I (2) = 90%, CHI(2) = 48.21, P < 0.01) AND DIASTOLIC BLOOD PRESSURE (6 RCTS, N = 278; MD = -7.22 MM HG, 95% CI = -12.83 TO -1.62, P = 0.01; HETEROGENEITY: I (2) = 92%, CHI(2) = 64.84, P < 0.01). SUBGROUP ANALYSES REVEALED EFFECTS FOR RCTS THAT INCLUDED HYPERTENSIVE PATIENTS BUT NOT FOR RCTS THAT INCLUDED BOTH HYPERTENSIVE AND PREHYPERTENSIVE PATIENTS, AS WELL AS FOR RCTS THAT ALLOWED ANTIHYPERTENSIVE COMEDICATION BUT NOT FOR THOSE THAT DID NOT. MORE ADVERSE EVENTS OCCURRED DURING YOGA THAN DURING USUAL CARE. COMPARED WITH EXERCISE, NO EVIDENCE WAS FOUND FOR EFFECTS OF YOGA ON SYSTOLIC OR DIASTOLIC BLOOD PRESSURE. CONCLUSIONS: LARGER STUDIES ARE REQUIRED TO CONFIRM THE EMERGING BUT LOW-QUALITY EVIDENCE THAT YOGA MAY BE A USEFUL ADJUNCT INTERVENTION IN THE MANAGEMENT OF HYPERTENSION. 2014 12 1849 43 QUASI PROSPECTIVE COMPARATIVE STUDY ON EFFECT OF YOGA AMONG PREDIABETICS ON PROGRESSION OF CARDIOVASCULAR RISK FACTORS. INTRODUCTION: PREDIABETIC PATIENTS HAVE HIGHER RISK FOR CARDIOVASCULAR DISEASES, WHICH FURTHER INCREASES THE RATE OF MORTALITY. REASON FOR THE RATE OF INCREASE MAY BE LACK OF OBSERVATION, FOLLOW-UP PROGRAMS, AND SELF-AWARENESS ABOUT THE CONDITIONS OF DISEASE. LIFESTYLE INTERVENTIONS SUCH AS YOGA CAN PROVE TO BE A BENEFICIAL NONPHARMACOLOGIC INTERVENTION IN PREVENTING PROGRESSION OF PREDIABETES TO TYPE 2 DIABETES. THIS STUDY HIGHLIGHTS IMPORTANCE OF SHORT-TERM INTERVENTION, I.E., YOGA IN PREDIABETIC PATIENTS AND USE IT AS A TOOL FOR PRIMARY PREVENTION OF DIABETES. METHODS: THIS WAS AN INTERVENTIONAL STUDY AMONG ADULTS AGED 30-50 YEARS IN RUHS COLLEGE OF MEDICAL SCIENCES AND ASSOCIATED RUKMANI DEVI BENI PRASAD JAIPURIA HOSPITAL IN JAIPUR CITY. THE DESIGN OF STUDY WAS QUASI PROSPECTIVE COMPARATIVE STUDY. A TOTAL OF 102 PREDIABETIC PATIENTS OF AGE GROUP 30-50 YEARS WERE RECRUITED FROM JAIPURIA HOSPITAL. THESE WERE DIVIDED INTO TWO GROUPS: STUDY GROUP (GROUP A, N = 51) WERE ENGAGED IN YOGA SESSION AND CONTROL GROUP (B, N = 51) NOT PERFORMED ANY YOGA SESSION. RESULTS: YOGA INTERVENTION RESULTED IN A SIGNIFICANT DECLINE IN BLOOD GLUCOSE (P < 0.001), GLYCATED HEMOGLOBIN (P < 0.01), LIPID PROFILE CHOLESTEROL (P < 0.01), TRIGLYCERIDE (P < 0.01), AND LOW-DENSITY LIPOPROTEIN (P < 0.01), BUT HIGH-DENSITY LIPOPROTEIN (P < 0.02) AND VERY LOW-DENSITY LIPOPROTEIN INCREASE (P < 0.03) BUT NOT STATISTICALLY SIGNIFICANT RELATIVE TO THE CONTROL GROUP. CONCLUSION: SHORT-TERM YOGA INTERVENTION IS HELPFUL IN THE CONTROL OF GLYCEMIC PARAMETERS LIKE BLOOD GLUCOSE, GLYCATED HEMOGLOBIN AND LIPID PROFILE IN PREDIABETIC PATIENTS. THIS PRELIMINARY STUDY INDICATES THAT A YOGA PROGRAM WOULD BE A POSSIBLE RISK REDUCTION OPTION FOR ADULTS AT HIGH RISK FOR TYPE 2 DIABETES. IN ADDITION, YOGA HOLDS PROMISE AS AN APPROACH TO REDUCING CARDIOMETABOLIC RISK FACTORS AND INCREASING EXERCISE SELF-EFFICACY FOR PREDIABETICS PERFORMING YOGA. 2019 13 1053 40 EFFECTS OF YOGA ON CARDIOVASCULAR DISEASE RISK FACTORS: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY ASSESS AND META-ANALYZE THE EFFECTS OF YOGA ON MODIFIABLE BIOLOGICAL CARDIOVASCULAR DISEASE RISK FACTORS IN THE GENERAL POPULATION AND IN HIGH-RISK DISEASE GROUPS. METHODS: MEDLINE/PUBMED, SCOPUS, THE COCHRANE LIBRARY, AND INDMED WERE SCREENED THROUGH AUGUST 2013 FOR RANDOMIZED CONTROLLED TRIALS (RCTS) ON YOGA FOR PREDEFINED CARDIOVASCULAR RISK FACTORS IN HEALTHY PARTICIPANTS, NON-DIABETIC PARTICIPANTS WITH HIGH RISK FOR CARDIOVASCULAR DISEASE, OR PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS. RISK OF BIAS WAS ASSESSED USING THE COCHRANE RISK OF BIAS TOOL. RESULTS: FORTY-FOUR RCTS WITH A TOTAL OF 3168 PARTICIPANTS WERE INCLUDED. RISK OF BIAS WAS HIGH OR UNCLEAR FOR MOST RCTS. RELATIVE TO USUAL CARE OR NO INTERVENTION, YOGA IMPROVED SYSTOLIC (MEAN DIFFERENCE (MD)=-5.85 MM HG; 95% CONFIDENCE INTERVAL (CI)=-8.81, -2.89) AND DIASTOLIC BLOOD PRESSURE (MD=-4.12 MM HG; 95%CI=-6.55, -1.69), HEART RATE (MD=-6.59 BPM; 95%CI=-12.89, -0.28), RESPIRATORY RATE (MD=-0.93 BREATHS/MIN; 95%CI=-1.70, -0.15), WAIST CIRCUMFERENCE (MD=-1.95 CM; 95%CI=-3.01, -0.89), WAIST/HIP RATIO (MD=-0.02; 95%CI=-0.03, -0.00), TOTAL CHOLESTEROL (MD=-13.09 MG/DL; 95%CI=-19.60, -6.59), HDL (MD=2.94 MG/DL; 95%CI=0.57, 5.31), VLDL (MD=-5.70 MG/DL; 95%CI=-7.36, -4.03), TRIGLYCERIDES (MD=-20.97 MG/DL; 95%CI=-28.61, -13.32), HBA1C (MD=-0.45%; 95%CI=-0.87, -0.02), AND INSULIN RESISTANCE (MD=-0.19; 95%CI=-0.30, -0.08). RELATIVE TO EXERCISE, YOGA IMPROVED HDL (MD=3.70 MG/DL; 95%CI=1.14, 6.26). CONCLUSIONS: THIS META-ANALYSIS REVEALED EVIDENCE FOR CLINICALLY IMPORTANT EFFECTS OF YOGA ON MOST BIOLOGICAL CARDIOVASCULAR DISEASE RISK FACTORS. DESPITE METHODOLOGICAL DRAWBACKS OF THE INCLUDED STUDIES, YOGA CAN BE CONSIDERED AS AN ANCILLARY INTERVENTION FOR THE GENERAL POPULATION AND FOR PATIENTS WITH INCREASED RISK OF CARDIOVASCULAR DISEASE. 2014 14 823 41 EFFECT OF YOGA ON GLUCOSE CONTROL AND QUALITY OF LIFE IN PATIENTS OF PREDIABETES. OBJECTIVE: THE OBJECTIVE OF THIS STUDY WAS TO EVALUATE EFFECT OF YOGA ON FASTING PLASMA GLUCOSE (FPG), POSTPRANDIAL PLASMA GLUCOSE, AND HEMOGLOBIN A1C (HBA1C) AND ALSO ON QUALITY OF LIFE (QOL). RESEARCH DESIGN AND METHODS: THIS WAS A COHORT STUDY IN WHICH 100 DIAGNOSED CASES OF PREDIABETES WERE RECRUITED FOR DOING SPECIFIC YOGA, AND THEY THEMSELVES ACT AS CONTROL FOR THE STUDY. THE MEASUREMENT AND COMPARISON OF FPG, PRANDIAL PLASMA GLUCOSE (PPG), AND HBA1C WERE DONE AT THREE DIFFERENT TIME INTERVALS, THAT IS, BASELINE, 3 MONTHS, AND AT 6 MONTHS. THE ASSESSMENT OF QOL WAS DONE USING SF-36 SCALE. RESULTS: ONE HUNDRED PREDIABETIC CASES WERE SELECTED FOR THE STUDY IN WHICH IMPAIRED FASTING GLUCOSE (IFG) WAS PRESENT MORE IN YOUNGER POPULATION COMPARED TO IMPAIRED GLUCOSE TOLERANCE (IGT) AND IFG PLUS IGT BOTH OF WHICH ARE MORE PREVALENT IN MIDDLE AGE GROUP. THE YOGA THERAPY WAS FOUND TO HAVE FAVORABLE EFFECT ON FPG, PPG, AND HBA1C ALONG WITH VARIOUS ANTHROPOMETRY MEASURES STUDIED IN THIS STUDY. AFTER ADJUSTING CORRELATION COEFFICIENT FOR VARIOUS ANTHROPOMETRY MEASURES, YOGA WAS FOUND TO BE EFFECTIVE FOR CONTROLLING GLYCEMIC PARAMETERS IN PREDIABETICS. CONCLUSIONS: YOGA IS A TYPE OF EXERCISE KNOWN TO IMPROVE GLYCEMIC CONTROL BY CHANGING ANTHROPOMETRY MEASURES, BUT OUR STUDY AIDS IN KNOWLEDGE ABOUT THE BENEFICIAL EFFECT BEYOND THIS KNOWN FACT THROUGH OTHER MECHANISMS YET TO BE EXPLORED. 2021 15 937 48 EFFECTIVENESS OF YOGA-BASED EXERCISE PROGRAM COMPARED TO USUAL CARE, IN IMPROVING HBA1C IN INDIVIDUALS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROL TRIAL. BACKGROUND: THIS STUDY WAS DESIGNED TO EVALUATE THE EFFECTIVENESS OF A YOGA-BASED EXERCISE PROGRAM (YBEP) IN IMPROVING GLYCEMIC CONTROL IN PEOPLE WITH TYPE 2 DIABETES MELLITUS. MATERIALS AND METHODS: PATIENTS ON STABLE ORAL GLUCOSE-LOWERING AGENTS FOR AT LEAST 3 MONTHS AND HBA1C 7.5%-10% WERE RANDOMIZED IN 1:1 RATIO. THE PRIMARY OUTCOME MEASURE WAS THE DIFFERENCE OF CHANGE IN MEAN HBA1C BETWEEN GROUPS. RESULTS: THE PARTICIPANTS (N = 81) HAD MEAN (+/-STANDARD DEVIATION) AGE OF 50.6 (+/-8.5) YEARS AND HBA1C OF 8.5 +/- 0.7% (68.97 +/- 7.42 MMOL/MOL). THE FOLLOW-UP DATA WERE AVAILABLE IN 96% (78/81) OF PARTICIPANTS. OF 40 PARTICIPANTS, 25 (62.5%) ATTENDED >/=75% (>/=10 OUT OF 13) OF THE SESSIONS IN YBEP. ON THE INTENTION TO TREAT ANALYSIS, A FAVORABLE REDUCTION (0.21% 95% CONFIDENCE INTERVAL [-0.34, 0.75], P = 0.454) IN HBA1C WAS SEEN IN YBEP GROUP AS COMPARED TO USUAL CARE. THE REDUCTION IN HBA1C BY >/=0.5% WAS OBSERVED IN 44.7% OF PARTICIPANTS IN YBEP AS COMPARED TO 37.5% IN USUAL CARE ARM, RESPECTIVELY. THOSE WHO ATTENDED >/=75% OF THE SESSIONS HAD BETTER HBA1C REDUCTION OF 0.3% IN COMPARISON TO 0.1% REDUCTION SEEN IN THOSE WHO ATTENDED <75% OF THE SESSIONS. CONCLUSIONS: YBEP DEMONSTRATED A CLINICALLY RELEVANT HBA1C REDUCTION COMPARED TO USUAL CARE IN PARTICIPANTS WHO HAD ATTENDED AT LEAST 75% OF THE YOGA SESSIONS. THE REDUCTION IN HBA1C BY >0.5% IN 44.7% IN THE YOGA GROUP, SUGGESTS, THAT IT CAN BE PRESCRIBED AS AN EXERCISE TO INDIVIDUALS WHO ARE UNABLE TO WALK EITHER DUE TO LIMITED JOINT MOBILITY, ADVERSE WEATHER CONDITIONS, LACK OF SPACE FOR WALKING, CULTURAL OR RELIGIOUS PROHIBITIONS FOR WOMEN FOR OUTDOOR PHYSICAL ACTIVITY, AND SO ON.CTRI REGISTRATION NO: CTRI/2017/05/008564. 2020 16 1476 32 INTEGRATED YOGA AND NATUROPATHY MODULE IN MANAGEMENT OF METABOLIC SYNDROME: A CASE REPORT. A 50-YEAR-OLD MALE PARTICIPANT WITH SEDENTARY LIFESTYLE, DIAGNOSED WITH METABOLIC SYNDROME (METS) [OBESITY, TYPE-2 DIABETES MELLITUS, HYPERTENSION] AND HYPOTHYROIDISM SINCE 2013, WAS ADMINISTERED INTEGRATED YOGA AND NATUROPATHY (IYN) FOR 6 WEEKS AS A TAILOR MADE INDIVIDUALIZED PROTOCOL AT THE RESIDENTIAL INTEGRATIVE MEDICAL FACILITY IN BANGALORE BETWEEN OCTOBER AND NOVEMBER 2015. THE RESULTS SHOWED REDUCTION IN WEIGHT (97.9 KG TO 74.6 KG), BODY MASS INDEX (BMI) (35.1 KG/M(2) TO 27.86 KG/M(2)), TOTAL CHOLESTEROL (192 MG% TO 145 MG%), TRIGLYCERIDES (153 MG% TO 90 MG%), LOW DENSITY LIPOPROTEIN (LDL) (124 MG% TO 81 MG%), HIGH DENSITY LIPOPROTEIN (HDL) (40 MG% TO 46 MG%), FASTING BLOOD GLUCOSE (110 MG/DL TO 75 MG/DL), POSTPRANDIAL GLUCOSE (267 MG/DL TO 100 MG/DL), GLYCATED HEMOGLOBIN (HBA1C) (7.8%-7.1%), THYROID STIMULATING HORMONE (TSH) (6.90 MUIU/ML TO 3.052 MUIU/ML). FOLLOWING THE INTERVENTION, THE ANTI-HYPERTENSIVE, ORAL HYPOGLYCEMIC, THYROID RAISING AND ANALGESIC MEDICINES WERE NOT REQUIRED TO BE CONTINUED. HIS KNEE PAIN MINIMIZED ON DISCHARGE AS OBSERVED ON A VISUAL ANALOG SCALE. HE HAD AN IMPROVED FEELING OF WELLNESS AND OVERALL FUNCTIONAL HEALTH. ALL HIS PARAMETERS WERE WITHIN NORMAL RANGE AT THE 12-WEEKS FOLLOW-UP, AS HE HAD INCORPORATED THE LIFESTYLE PROGRAM INTO HIS DAILY ROUTINE. THIS CASE REPORT SUGGESTS THAT LIFESTYLE CHANGE BY INTEGRATION OF SPECIFIC NON-DRUG YOGA AND NATUROPATHIC INTERVENTION IS USEFUL IN THE MANAGEMENT OF METS. 2017 17 663 37 EFFECT OF 6 MONTHS INTENSE YOGA PRACTICE ON LIPID PROFILE, THYROXINE MEDICATION AND SERUM TSH LEVEL IN WOMEN SUFFERING FROM HYPOTHYROIDISM: A PILOT STUDY. BACKGROUND: A SIGNIFICANT NUMBER OF WOMEN IN INDIA ARE SUFFERING FROM HYPOTHYROIDISM. HYPOTHYROIDISM IS CHARACTERIZED BY ELEVATED LIPID PROFILES AND THYROID STIMULATION HORMONE (TSH). IT LEADS MANY COMORBID CONDITIONS SUCH AS CORONARY ARTERY DISEASE, OBESITY, DEPRESSION, OSTEOPOROSIS, SLEEP APNEA, AND ETC. YOGA IS PROVEN TO BE EFFECTIVE IN REDUCING WEIGHT, DYSLIPIDEMIA, DEPRESSION AND IT BRINGS THE BALANCE IN AUTONOMOUS NERVOUS SYSTEM. WE AIMED TO STUDY THE EFFECT OF 6 MONTHS YOGA PRACTICE ON LIPID PROFILE, THYROXINE REQUIREMENT AND SERUM TSH IN WOMEN SUFFERING FROM HYPOTHYROIDISM. METHODS: TWENTY-TWO HOUSEHOLD WOMEN SUFFERING FROM HYPOTHYROIDISM BETWEEN THE AGE RANGE OF 30 AND 40 (MEAN+/-SD; 36.7+/-3.2) YEARS, WITH AVERAGE 4+/-1.12-YEAR HISTORY OF HYPOTHYROIDISM WERE INCLUDED IN THIS STUDY. SUBJECTS WITH KNOWN CARDIAC ISSUES, HYPERTENSION, HISTORY, RECENT SURGERY, SLIP DISC AND LOW BACK PAIN WERE EXCLUDED FROM THIS STUDY. NONE OF THE SUBJECTS WERE ON ANY OTHER MEDICATION EXCEPT THYROXINE WHICH WAS KEPT DURING THE INTERVENTION PHAGE (MEAN 65.78+/-22.74 MCG). ALL THE SUBJECTS UNDERWENT 6 MONTHS OF YOGA PRACTICE 1 H DAILY FOR 4 DAYS A WEEK. LIPID PROFILE, THYROXINE DOSAGE AND SERUM TSH LEVEL WERE ASSESSED BEFORE AND AFTER INTERVENTION. DATA WAS ANALYZED USING PAIRED SAMPLE T TEST & WILCOXON'S SIGNED RANK TEST. RESULTS: THE PAIRED SAMPLE T-TEST SHOWED SIGNIFICANT REDUCTION IN TOTAL CHOLESTEROL (P=0.006; -8.99%), LOW-DENSITY LIPOPROTEIN (LDL) (P=0.002; -9.81%) AND TRIGLYCERIDES (P=0.013; -7.6%), AND THERE WAS A SIGNIFICANT IMPROVEMENT IN HIGH-DENSITY LIPOPROTEIN (HDL) (P=0.02; +9.65%) ALONG WITH NONSIGNIFICANT REDUCTION IN TSH LEVEL (P=0.452; -9.72%). WILCOXON SIGNED-RANK TEST SHOWED SIGNIFICANT REDUCTION IN THYROXINE MEDICATION SCORE (P=0.029; -15.30%) FROM. CONCLUSION: 6 MONTHS PRACTICE OF YOGA MAY HELP IN IMPROVING CHOLESTEROL LEVEL, SERUM TSH, MAY ALSO HELP IN REDUCING THE THYROXINE REQUIREMENT IN FEMALE PATIENTS SUFFERING FROM HYPOTHYROIDISM. HOWEVER, FURTHER RANDOMIZED CONTROLLED STUDIES NEED TO BE CONDUCTED TO CONFIRM THE PRESENT FINDING. 2016 18 930 34 EFFECTIVENESS OF YOGA PROGRAM IN THE MANAGEMENT OF DIABETES USING COMMUNITY HEALTH WORKERS IN THE URBAN SLUMS OF BANGALORE CITY: A NON-RANDOMIZED CONTROLLED TRIAL. TRIAL DESIGN: NONRANDOMIZED CONTROLLED TRIAL. METHODS: NONRANDOMIZED CONTROLLED TRIAL. THIS WAS AN INTERVENTIONAL STUDY THAT WAS CONDUCTED IN 4 SLUMS OF BENGALURU. OF THE 256 DIABETES PARTICIPANTS, ONLY 109 PEOPLE AGREED TO PARTICIPATE IN THE PROGRAM. OF 109 PEOPLE, 52 PEOPLE AGREED TO PARTICIPATE IN THE INTERVENTION (AGREED TO LEARN AND PRACTICE YOGA) WHILE THE REMAINING 57 PEOPLE WERE ASSIGNED TO NONINTERVENTION GROUP. RANDOMIZATION AND BLINDING COULD NOT BE DONE. OBJECTIVE AND OUTCOME: THE STUDY WAS CONDUCTED WITH OBJECTIVE OF ASSESSING THE EFFECTIVENESS OF YOGA, PRANAYAMA, AND SUDARSHAN KRIYA IN THE COMMUNITY-BASED MANAGEMENT OF DIABETES MELLITUS. THE PRIMARY OUTCOME VARIABLE WAS HB1AC AND SECONDARY OUTCOME VARIABLES WERE SYSTOLIC BLOOD PRESSURE (SBP), DIASTOLIC BLOOD PRESSURE (DBP), ADHERENCE TO MEDICATION, AND CHANGES IN LIFESTYLE. RESULTS: THE STUDY WAS CONDUCTED FOR 40 DAYS. COMMUNITY HEALTH WORKERS MADE A TOTAL OF 6 VISITS DURING THE STUDY. ALL THE 109 PARTICIPANTS WERE AVAILABLE FOR WEEKLY FOLLOW-UP. THERE WERE NO DROP OUTS AMONG THE STUDY POPULATION. STATISTICALLY SIGNIFICANT CHANGE WAS SEEN IN THE CONSUMPTION OF VEGETABLE (CHI(2) = 15.326, P < 0.005), FRUITS (CHI(2) = 16.207, P < 0.005), SALTY FOOD (CHI(2) = 14.823, P < 0.005), BAKERY FOOD (CHI(2) = 10.429, P < 0.005) AND FRIED FOOD (CHI(2) = 15.470, P < 0.005), ADHERENCE TO METFORMIN (CHI(2) = 41.780, P < 0.005) AND OTHER MEDICATION(CHI(2) = 21.871, P < 0.005) AND PROPORTION OF PATIENTS WITH DBP UNDER CONTROL (CHI(2) = 9.396, P < 0.005) AND PROPORTION OF PEOPLE WITH GLUCOSE RANDOM BLOOD SUGAR UNDER CONTROL (CHI(2) = 29.693, P < 0.005) BETWEEN THE TWO GROUPS FOLLOWING THE INTERVENTION. STATISTICALLY SIGNIFICANT CHANGE WAS ALSO SEEN IN THE PROPORTION OF PEOPLE WITH SBP/DBP